Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;91:1336-1340

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kugelmass, A. D.
Right arrow Articles by Ware, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kugelmass, A. D.
Right arrow Articles by Ware, J. A.

(Circulation. 1995;91:1336-1340.)
© 1995 American Heart Association, Inc.


Articles

Intravenous Cocaine Induces Platelet Activation in the Conscious Dog

Aaron D. Kugelmass, MD; Richard P. Shannon, MD; Erik L. Yeo, MD; J. Anthony Ware, MD

From the Charles A. Dana Research Institute and the Harvard-Thorndike Laboratory of the Department of Medicine, Beth Israel Hospital and Harvard Medical School, Boston, Mass (A.D.K., R.P.S., J.A.W.); the New England Regional Primate Research Center, Southborough, Mass (R.P.S.); and the Hematology Division, The Toronto Hospital, Toronto, Ontario (E.L.Y.).

Correspondence to J. Anthony Ware, MD, Cardiovascular Division, Beth Israel Hospital, 330 Brookline Ave, Boston, MA 02215.

Background Cocaine consumption has been associated with thrombosis of coronary and peripheral arteries. Since cocaine has been found to induce platelet activation in vitro, we sought to establish whether cocaine induced platelet activation in vivo.

Methods and Results Chronically instrumented, conscious dogs were infused with cocaine (1 mg/kg), norepinephrine (0.2 to 0.4 mg/kg), or saline intravenously over 1 minute. Activated canine platelets were identified in whole blood collected from an indwelling aortic catheter by flow cytometric detection of the binding of a monoclonal antibody directed against the activation-dependent antigen P-selectin. Infusion of cocaine resulted in an elevation of mean arterial pressure (91±3 to 128±7 mm Hg [P<.001]) and heart rate (87±9 to 125±11 beats per minute [P<.01]). A similar change (P=NS) in mean arterial pressure followed norepinephrine infusion (100±5 to 137±13 mm Hg [P<.04]), whereas saline infusion had no effect. Cocaine resulted in a substantial but delayed increase in platelet P-selectin expression (14±7% [P<.08], 31±12% [P<.04], and 55±22% [P<.04] at 17, 22, and 27 minutes after drug infusion, respectively). The magnitude of this increase was similar to that found in blood treated ex vivo with the agonists ADP or PAF (23±7% and 53±15%, respectively). No significant increase in P-selectin expression was detected in the blood of animals that received norepinephrine or saline. Serum cocaine concentrations were highest immediately after infusion (538±55 ng/mL at 2 minutes) but declined rapidly (185±22 and 110±25 ng/mL at 17 and 32 minutes after infusion); in contrast, the increase in benzoylecgonine concentrations was delayed (from <25 ng/mL in all but one animal [34 ng/mL] at 2 minutes to 46±4 and 71±11 ng/mL at 17 and 32 minutes, respectively, after infusion).

Conclusions Intravenous cocaine induces activation of individual circulating platelets; this effect is not reproduced by infusion of norepinephrine at doses sufficient to exert similar hemodynamic effects. The delay in detection of activated platelets after treatment with cocaine may result from the adhesion and subsequent detachment of activated platelets; alternatively, cocaine metabolites, rather than the drug itself, may induce platelet activation.


Key Words: cocaine • norepinephrine • proteins • cells




This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
S. D Treadwell and T. G Robinson
Cocaine use and stroke
Postgrad. Med. J., June 1, 2007; 83(980): 389 - 394.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
J. A. Jaffe and P. L. Kimmel
Chronic Nephropathies of Cocaine and Heroin Abuse: A Critical Review
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 655 - 667.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
M Egred and G K Davis
Cocaine and the heart
Postgrad. Med. J., September 1, 2005; 81(959): 568 - 571.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Satran, B. A. Bart, C. R. Henry, M. B. Murad, S. Talukdar, D. Satran, and T. D. Henry
Increased Prevalence of Coronary Artery Aneurysms Among Cocaine Users
Circulation, May 17, 2005; 111(19): 2424 - 2429.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Chen, Q. Ke, Y.-F. Xiao, G. Wu, E. Kaplan, T. G. Hampton, S. Malek, J.-Y. Min, I. Amende, and J. P. Morgan
Cocaine and catecholamines enhance inflammatory cell retention in the coronary circulation of mice by upregulation of adhesion molecules
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2323 - H2331.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Kokado, M. Shimizu, H. Yoshio, H. Ino, K. Okeie, Y. Emoto, T. Matsuyama, M. Yamaguchi, T. Yasuda, N. Fujino, et al.
Clinical Features of Hypertrophic Cardiomyopathy Caused by a Lys183 Deletion Mutation in the Cardiac Troponin I Gene
Circulation, August 8, 2000; 102(6): 663 - 669.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
V. J. Marder and I. K. Mellinghoff
Cocaine and Buerger Disease: Is There a Pathogenetic Association?
Arch Intern Med, July 10, 2000; 160(13): 2057 - 2060.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C M Heesch, C R Wilhelm, J Ristich, J Adnane, F A Bontempo, and W R Wagner
Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans
Heart, June 1, 2000; 83(6): 688 - 695.
[Abstract] [Full Text]


Home page
Journal of Pharmacy PracticeHome page
J. W. Lipton, K. P. Mangan, and J. M. Silvestri
Acute Cocaine Toxicity: Pharmacology and Clinical Presentations in Adult and Pediatric Populations
Journal of Pharmacy Practice, April 1, 2000; 13(2): 159 - 169.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. J. Tanhehco, K. Yasojima, P. L. McGeer, and B. R. Lucchesi
Acute Cocaine Exposure Up-Regulates Complement Expression in Rabbit Heart
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 201 - 208.
[Abstract] [Full Text]


Home page
Postgrad. Med. J.Home page
J. Sztajzel, F. Mach, and A. Righetti
Current concepts in medicine: Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries
Postgrad. Med. J., January 1, 2000; 76(891): 16 - 21.
[Abstract] [Full Text]


Home page
CirculationHome page
M. A. Mittleman, D. Mintzer, M. Maclure, G. H. Tofler, J. B. Sherwood, and J. E. Muller
Triggering of Myocardial Infarction by Cocaine
Circulation, June 1, 1999; 99(21): 2737 - 2741.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
U. Wilbert-Lampen, C. Seliger, T. Zilker, and R. M. Arendt
Cocaine Increases the Endothelial Release of Immunoreactive Endothelin and Its Concentrations in Human Plasma and Urine : Reversal by Coincubation With {sigma}-Receptor Antagonists
Circulation, August 4, 1998; 98(5): 385 - 390.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. E. Hollander, D. E. Brooks, and S. M. Valentine
Assessment of Cocaine Use in Patients With Chest Pain Syndromes
Arch Intern Med, January 12, 1998; 158(1): 62 - 66.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. P. Shannon, P. Lozano, Q. Cai, W. T. Manders, and Y.-t. Shen
Mechanism of the Systemic, Left Ventricular, and Coronary Vascular Tolerance to a Binge of Cocaine in Conscious Dogs
Circulation, August 1, 1996; 94(3): 534 - 541.
[Abstract] [Full Text]